European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says

The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age and older. The CBD-based medicine was greenlighted in Europe […] European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Source: MjBizDaily.com
European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says

Please follow and like us:

Gman

Archives

Calendar

September 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
30